A phase 1 study of CVT-427 for relief of acute migraine
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Zolmitriptan (Primary)
- Indications Migraine
- Focus Adverse reactions
- 09 Jun 2016 According to an Acorda Therapeutics media release, results of this trial were presented at the 58th Annual Scientific Meeting of the American Headache Society, 2016.
- 11 Feb 2016 According to an Acorda Therapeutics media release, an updates from this trial will be provided by end of the first quarter 2016.
- 11 Feb 2016 Status changed from planning to completed, as per an Acorda Therapeutics media release.